LUTRATE DEPOT KIT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lutrate Depot Kit, and when can generic versions of Lutrate Depot Kit launch?
Lutrate Depot Kit is a drug marketed by Gp-pharm Sa and is included in one NDA.
The generic ingredient in LUTRATE DEPOT KIT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lutrate Depot Kit
A generic version of LUTRATE DEPOT KIT was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
Summary for LUTRATE DEPOT KIT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 5 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | LUTRATE DEPOT KIT at DailyMed |
Recent Clinical Trials for LUTRATE DEPOT KIT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| City of Hope Medical Center | Phase 2 |
| National Cancer Institute (NCI) | Phase 2 |
| ECOG-ACRIN Cancer Research Group | Phase 3 |
US Patents and Regulatory Information for LUTRATE DEPOT KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gp-pharm Sa | LUTRATE DEPOT KIT | leuprolide acetate | FOR SUSPENSION;INTRAMUSCULAR | 205054-001 | Aug 28, 2018 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LUTRATE DEPOT KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Gp-pharm Sa | LUTRATE DEPOT KIT | leuprolide acetate | FOR SUSPENSION;INTRAMUSCULAR | 205054-001 | Aug 28, 2018 | See Plans and Pricing | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LUTRATE DEPOT KIT
See the table below for patents covering LUTRATE DEPOT KIT around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Australia | 2173501 | See Plans and Pricing | |
| Brazil | PI0008197 | microcápsulas para a liberação prolongada de fármacos | See Plans and Pricing |
| Germany | 60001717 | See Plans and Pricing | |
| European Patent Office | 1151746 | MICROCAPSULES POUR LA LIBERATION PROLONGEE DE MEDICAMENTS (MICROCAPSULES FOR SUSTAINED RELEASE OF DRUGS) | See Plans and Pricing |
| Austria | 234608 | See Plans and Pricing | |
| Brazil | 0008197 | See Plans and Pricing | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
NCE-1 Patent Challenge Dates 2022 - 2023
ClinicalTrialExchange - Connecting volunteers and trials
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
